315 - Engraftment syndrome, sinusoidal obstruction syndrome and multi-organ dysfunction following auto hematopoietic stem cell transplantation in a multiple myeloma patient

Autor: Robertson, A, Al-sawajneh, S Mufadi

Publikováno v: In The American Journal of the Medical Sciences February 2024 367 Supplement 1:S186-S186

Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients.

Autor: Halahleh K; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan. Electronic address: Kh.06314@khcc.jo., Al Sawajneh S; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Saleh Y; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Shahin O; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Abufara A; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Ma'koseh M; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Abdel-Razeq R; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Barakat F; Department of Hematopathology, King Hussein Cancer Center, Amman, Jordan., Abdelkhaleq H; Biostatistics Unit, Research Office, King Hussein Cancer Center, Amman, Jordan., Al-Hassan N; Department of Nursing, King Hussein Cancer Center, Amman, Jordan., Atiyyat R; Department of Nursing, King Hussein Cancer Center, Amman, Jordan., Al-Faker N; Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan., Omari Z; Department of Radiology, King Hussein Cancer Center, Amman, Jordan., Ghatasheh H; Department of Radiotherapy, King Hussein Cancer Center, Amman, Jordan., Jaradat I; Department of Radiotherapy, King Hussein Cancer Center, Amman, Jordan., Muradi I; Department of Medicine, University of Tripoli, Tripoli, Libya., Iyad S; Department of Pediatrics, Medical Oncology-Hematology, King Hussein Cancer Center, Amman, Jordan., Bazarbachi A; Bone Marrow Transplantation Department, American University of Beirut, Beirut, Lebanon.

Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Aug; Vol. 22 (8), pp. 589-595. Date of Electronic Publication: 2022 Mar 04.

Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies.

Autor: Mo, Christiana^1,2 (AUTHOR) cmo3@montefiore.org, Sterpi, Michelle^1,2 (AUTHOR) msterpi@montefiore.org, Jeon, Hyein^1,2 (AUTHOR) hyjeon@montefiore.org, Bteich, Fernand^1,2 (AUTHOR) fbteich@montefiore.org

Publikováno v: Cancers. Aug2024, Vol. 16 Issue 16, p2854. 22p.

Prognosis in HR-positive metastatic breast cancer with HER2-low versus HER2-zero treated with CDK4/6 inhibitor and endocrine therapy: a meta-analysis.

Autor: Lin-Yu Xia, Xu-Chen Cao, Qing-Lin Hu, Wei-Yun Xu

Publikováno v: Frontiers in Oncology; 2024, p1-10, 10p

Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma.

Autor: Hazane Leroyer, Esther¹ (AUTHOR), Ziegler, Caroline¹ (AUTHOR), Moulin, Charline¹ (AUTHOR), Campidelli, Arnaud¹ (AUTHOR), Jacquet, Caroline¹ (AUTHOR), Rubio, Marie Thérèse^1,2 (AUTHOR), Feugier, Pierre^1,3 (AUTHOR), Pagliuca, Simona^1,2 (AUTHOR) smnpag@gmail.com

Publikováno v: Journal of Clinical Medicine. Nov2022, Vol. 11 Issue 21, p6574. 25p.